India's Pharmaceutical Exports

Country Profile

Czech Republic

Czech Republic is a growing market for Indian pharmaceuticals — $55.2M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 75% of shipments, with vaccines contributing $107K. The compound annual growth rate since FY2015 stands at 4.5%.

🇨🇿 $55.2M · 1.6× growth since FY2015 · 4.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$55.2M
Exports FY2025–26 DGCIS
1.6×
Growth FY2015→2026
4.5%
CAGR FY2015→2026
75%
Medicines Share
5
Product Categories Supplied
Czech Republic is a growing market for Indian pharmaceuticals — $55.2M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 75% of shipments, with vaccines contributing $107K. The compound annual growth rate since FY2015 stands at 4.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $41.3M (74.9%) Medicine Ingredients $11.5M (20.8%) Surgical & Hospital Supplies $1.50M (2.7%) Traditional & Herbal $733K (1.3%) Vaccines $107K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Czech Republic in the RBI overseas direct investment dataset (2011–2026).